02-09-2021, 07:15 PM
(This post was last modified: 02-09-2021, 07:25 PM by Glow.
Edit Reason: Edited to add a second paragraph from the article
)
You might like this article Diana.
It’s from the Toronto(Canada) Star.
COVID could spell the end of animal testing as drug makers turn to human organs on microchips
https://www.google.ca/amp/s/www.thestar....sting.html
“ The virulence and highly contagious nature of COVID-19 is demanding a new model of research that bypasses animals, instead using human-biology-based testing. A growing number of scientists suggest that accelerated COVID-19 research is exposing animal modelling for what many have long claimed it to be: a scientific anachronism.
Equally problematic, if not even more eyebrow raising: 95 per cent of new drugs that enter clinical trials don’t make it to the market, according to the National Center for Advancing Translational Sciences, at the U.S. National Institutes of Health (NIH). In other words, the vast majority of new drugs fail once they move into human studies, despite appearing safe and effective in experiments with animals.”
It’s from the Toronto(Canada) Star.
COVID could spell the end of animal testing as drug makers turn to human organs on microchips
https://www.google.ca/amp/s/www.thestar....sting.html
“ The virulence and highly contagious nature of COVID-19 is demanding a new model of research that bypasses animals, instead using human-biology-based testing. A growing number of scientists suggest that accelerated COVID-19 research is exposing animal modelling for what many have long claimed it to be: a scientific anachronism.
Equally problematic, if not even more eyebrow raising: 95 per cent of new drugs that enter clinical trials don’t make it to the market, according to the National Center for Advancing Translational Sciences, at the U.S. National Institutes of Health (NIH). In other words, the vast majority of new drugs fail once they move into human studies, despite appearing safe and effective in experiments with animals.”